Cisplatin shows greater efficacy than gemcitabine when combined with nab-paclitaxel in metastatic triple-negative breast cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Cisplatin shows greater efficacy than gemcitabine when combined with nab-paclitaxel in metastatic triple-negative breast cancer ; volume:9 ; number:1 ; day:5 ; month:3 ; year:2019 ; pages:1-8 ; date:12.2019
Scientific reports ; 9, Heft 1 (5.3.2019), 1-8, 12.2019
- Klassifikation
-
Naturwissenschaften
- Urheber
-
Li, Yi
Zhao, Yannan
Gong, Chengcheng
Xie, Yizhao
Hu, Xichun
Zhang, Jian
Wang, Leiping
Zhang, Sheng
Cao, Jun
Tao, Zhonghua
Wang, Biyun
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-019-39314-y
- URN
-
urn:nbn:de:101:1-2019032418384379938102
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Li, Yi
- Zhao, Yannan
- Gong, Chengcheng
- Xie, Yizhao
- Hu, Xichun
- Zhang, Jian
- Wang, Leiping
- Zhang, Sheng
- Cao, Jun
- Tao, Zhonghua
- Wang, Biyun
- SpringerLink (Online service)
Ähnliche Objekte (12)
Caveolin-1 expression predicts efficacy of weekly nab-paclitaxel plus gemcitabine for metastatic breast cancer in the phase II clinical trial
The China-United States BIT negotiations: A Chinese perspective
Nab-paclitaxel and gemcitabine plus camrelizumab and radiotherapy versus nab-paclitaxel and gemcitabine alone for locally advanced pancreatic adenocarcinoma: a prospective cohort study
Phase II trial of nab-paclitaxel in metastatic breast cancer patients with visceral metastases
Pankreaskarzinom nab-Paclitaxel
Towards a sub-percent precision measurement of sin2 θ 13 with reactor antineutrinos
Ventral striatal dysfunction in cocaine dependence – difference mapping for subregional resting state functional connectivity
Breast cancer nab-Paclitaxel
Sulindac (K-80003) with nab-paclitaxel and gemcitabine overcomes drug-resistant pancreatic cancer
Real world evidence on gemcitabine and nab-paclitaxel combination chemotherapy in advanced pancreatic cancer
Leptomeningeal Carcinomatosis in a Patient with Pancreatic Cancer Responding to Nab-Paclitaxel plus Gemcitabine
Stem cell therapy: a novel treatment option for cerebral malaria?
Caveolin-1 expression predicts efficacy of weekly nab-paclitaxel plus gemcitabine for metastatic breast cancer in the phase II clinical trial
The China-United States BIT negotiations: A Chinese perspective
Nab-paclitaxel and gemcitabine plus camrelizumab and radiotherapy versus nab-paclitaxel and gemcitabine alone for locally advanced pancreatic adenocarcinoma: a prospective cohort study
Phase II trial of nab-paclitaxel in metastatic breast cancer patients with visceral metastases
Pankreaskarzinom nab-Paclitaxel
Towards a sub-percent precision measurement of sin2 θ 13 with reactor antineutrinos
Ventral striatal dysfunction in cocaine dependence – difference mapping for subregional resting state functional connectivity
Breast cancer nab-Paclitaxel
Sulindac (K-80003) with nab-paclitaxel and gemcitabine overcomes drug-resistant pancreatic cancer
Real world evidence on gemcitabine and nab-paclitaxel combination chemotherapy in advanced pancreatic cancer
Leptomeningeal Carcinomatosis in a Patient with Pancreatic Cancer Responding to Nab-Paclitaxel plus Gemcitabine
Stem cell therapy: a novel treatment option for cerebral malaria?
Caveolin-1 expression predicts efficacy of weekly nab-paclitaxel plus gemcitabine for metastatic breast cancer in the phase II clinical trial
The China-United States BIT negotiations: A Chinese perspective
Nab-paclitaxel and gemcitabine plus camrelizumab and radiotherapy versus nab-paclitaxel and gemcitabine alone for locally advanced pancreatic adenocarcinoma: a prospective cohort study
Phase II trial of nab-paclitaxel in metastatic breast cancer patients with visceral metastases
Pankreaskarzinom nab-Paclitaxel
Towards a sub-percent precision measurement of sin2 θ 13 with reactor antineutrinos
Ventral striatal dysfunction in cocaine dependence – difference mapping for subregional resting state functional connectivity
Breast cancer nab-Paclitaxel
Sulindac (K-80003) with nab-paclitaxel and gemcitabine overcomes drug-resistant pancreatic cancer
Real world evidence on gemcitabine and nab-paclitaxel combination chemotherapy in advanced pancreatic cancer
Leptomeningeal Carcinomatosis in a Patient with Pancreatic Cancer Responding to Nab-Paclitaxel plus Gemcitabine